BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction
BioHarvest Sciences Strengthens Balance Sheet by $$14.7 Million with Injection of $$10.9 Million Gross Proceeds and Additional $3.8 Million in Debt ReductionSeptember 22, 2025 6:32 AM EDT | Source: BioHarvest Sciences Inc.Rehovot, Israel--(Newsfile Corp. - September 22, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the successful completion of a series of ac ...